CTU: A Multicentre, Open-label, Phase 1/2 Study of IBI133 in Subjects with Unresectable, Locally Advanced or Metastatic Solid Tumours

  • Park, John (Primary Chief Investigator)
  • TAIDI, Gina (Clinical Trial Unit Staff)
  • Chester, Catherine (Clinical Trial Unit Staff)
  • Chapman, Nicola (Clinical Trial Unit Staff)
  • Martin, Lewis (Clinical Trial Unit Staff)

Project: Research

Project Details

Short titleCIBI133A101
AcronymCIBI133A101
StatusActive
Effective start/end date10/03/2428/02/29